tailieunhanh - Severe thrombocytopenia induced by tirofban after percutaneous coronary intervention: A case report

Tirofiban is a nonpeptide glycoprotein IIb/IIIa receptor antagonist used widely in patients subjected to percutaneous coronary intervention. While the usage of tirofiban sets an important clinical benefit, severe thrombocytopenia can occur with use of this agent. |

TÀI LIỆU LIÊN QUAN